Pineapple Express Cannabis (PNXP) Return on Invested Capital (2018 - 2020)

Pineapple Express Cannabis' (PNXP) quarterly Return on Invested Capital came in at 0.01% in Q4 2020, up 1.0% year-on-year from 0.01% in Q4 2019, and up 23.33% quarter-over-quarter from 0.01% in Q3 2020.

Pineapple Express Cannabis (PNXP) Return on Invested Capital (2018 - 2020) Analysis & Trends

Pineapple Express Cannabis has disclosed Return on Invested Capital across 3 years of filings, most recently posting 0.01% for Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 0.00%
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 0.01%
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 0.00%
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 0.00%
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 0.00%
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 0.00%
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 0.00%
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 0.00%
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 0.00%
10 Pineapple Express Cannabis - - - -

Historic Data

Download Data
DateValue
Oct 31, 2020 -0.01%
Jul 31, 2020 -0.01%
Apr 30, 2020 -0.04%
Jan 31, 2020 0.10%
Oct 31, 2019 -0.01%
Jan 31, 2019 -0.05%
Oct 31, 2018 -0.10%